0.599
Hyperfine Inc Aktie (HYPR) Neueste Nachrichten
Hyperfine Gets FDA Clearance For Optive AI Software, Marking Major Upgrade To Swoop MRI Imaging - Nasdaq
FDA OKs Hyperfine’s Optive AI Software for Swoop MR - Medical Product Outsourcing
Hyperfine Announces FDA Clearance Of Optive AI(TM) Software - marketscreener.com
Hyperfine announces FDA clearance of next-generation software - TipRanks
Hyperfine unveils advanced AI software for portable MRI By Investing.com - Investing.com Nigeria
Hyperfine unveils advanced AI software for portable MRI - Investing.com
Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System - Business Wire
Hyperfine Chairperson R. Scott Huennekens Resigns - MSN
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Lags Revenue Estimates - MSN
Hyperfine Holds Annual Stockholders Meeting - TipRanks
B. Riley Has Optimistic Outlook of Hyperfine Q3 Earnings - Defense World
B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.00 - Defense World
Hyperfine Inc. Earnings Call: Transition and Growth - TipRanks
Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference - 01net
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Price Target Lowered | HYPR Stock News - GuruFocus
Hyperfine price target lowered to $1 from $1.20 at B. Riley - TipRanks
B. Riley Reduces Price Target for Hyperfine (HYPR) After Sales M - GuruFocus
B. Riley Lowers Price Target on Hyperfine to $1 From $1.20, Keeps Buy Rating - marketscreener.com
Hyperfine (HYPR) Maintained as 'Buy' by B. Riley Securities, Pri - GuruFocus
Hyperfine Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Wells Fargo Updates Price Target and Rating for HYPR | HYPR Stoc - GuruFocus
Hyperfine (HYPR) Reports Lower Q1 Revenue, Optimistic About Futu - GuruFocus
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2025 Earnings Call Transcript - Insider Monkey
Hyperfine’s net loss for Q1 2025 hits USD 9.4M - Medical Buyer
Hyperfine outlines 10%–20% revenue growth for 2025 as new product launches and office market entry drive diversification - MSN
Hyperfine Q1 2025 Earnings Call Transcript - MarketBeat
Hyperfine, Inc. Reports Q1 2025 Financial Results - TipRanks
Hyperfine reports Q1 EPS (12c), consensus (12c) - TipRanks
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations By Investing.com - Investing.com Nigeria
Earnings call transcript: Hyperfine Misses Q1 2025 Revenue Expectations - Investing.com
Hyperfine Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results - Investing.com Australia
Hyperfine Q1 2025 slides reveal portable MRI expansion strategy despite mixed results By Investing.com - Investing.com South Africa
Hyperfine Inc (HYPR) Q1 2025 Earnings: EPS Meets Estimate at -$0 - GuruFocus
Hyperfine Inc Files For Offering Of Up To $50 Million Of Shares Of Class A Common Stock - marketscreener.com
Hyperfine, Inc. SEC 10-Q Report - TradingView
Hyperfine, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Hyperfine Inc (HYPR) Q1 2025 Earnings Report Preview: What To Lo - GuruFocus
Chipiron building ultra-low portable MRI scanner following $17M raise - BioWorld MedTech
Hyperfine (HYPR) Projected to Post Quarterly Earnings on Tuesday - Defense World
Renaissance Technologies LLC Boosts Stock Holdings in Hyperfine, Inc. (NASDAQ:HYPR) - Defense World
Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 - Business Wire
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices - 01net
Hyperfine Enrolls First Patients in Portable MRI Evaluation Study - marketscreener.com
Hyperfine enrolls initial patients in NEURO PMR study - TipRanks
Revolutionary Portable MRI Secures Medicare Coverage as Major Clinical Trial Launches - Stock Titan
Hyperfine (NASDAQ:HYPR) Stock Price Up 0.5% – Should You Buy? - Defense World
HYPR Stock Price and Chart — NASDAQ:HYPR - TradingView
HYPR stock touches 52-week low at $0.76 amid market challenges - Investing.com
Lake Street Initiates Coverage of Hyperfine (HYPR) with Buy Recommendation - MSN
Lake Street starts Hyperfine stock with Buy, sets $1.50 target By Investing.com - Investing.com Australia
Lake Street starts Hyperfine stock with Buy, sets $1.50 target - Investing.com
Lake Street Initiates Hyperfine at Buy With $1.50 Price Target -March 24, 2025 at 08:20 am EDT - MarketScreener
Hyperfine initiated with a Buy at Lake Street - TipRanks
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):